Dual agonists typically target GLP-1R, GIP (glucose-dependent insulinotropic polypeptide) or IGF (insulin-like growth factor) receptors, while triple agonists target GLP-1R, GIPR, and the glucagon receptor (GCGR)
The clinical significance of these differences for retatrutide specifically has not been studied, but experienced researchers report the most consistent results with abdominal injections following the standard dosage protocol
Suited to people with limited lower-belly looseness and no significant muscle separation
Knowing your genetic predisposition helps your care team personalize your semaglutide dose and monitoring schedule, ensuring you capture maximum blood pressure benefit while minimizing unnecessary dose escalation
Your experience will depend on factors such as dosing, lifestyle, and how your body responds
Seek Physical Therapy Physical therapy offers tailored solutions for persistent back pain